PD-L1 expression, Cancer Genome Atlas (TCGA) subtype, and mutational load as independent predictors of response to atezolizumab (atezo) in metastatic urothelial carcinoma (mUC; IMvigor210) Meeting Abstract
| Authors: | Rosenberg, J. E.; Petrylak, D. P.; Van Der Heijden, M. S.; Necchi, A.; O'Donnell, P. H.; Loriot, Y.; Retz, M.; Perez-Gracia, J. L.; Bellmunt, J.; Grivas, P.; Joseph, R. W.; Fong, L.; Kadel, E. E.; Boyd, Z.; Nickles, D.; Frampton, G. M.; Bourgon, R.; Hegde, P. S.; Mariathasan, S.; Powles, T. |
| Abstract Title: | PD-L1 expression, Cancer Genome Atlas (TCGA) subtype, and mutational load as independent predictors of response to atezolizumab (atezo) in metastatic urothelial carcinoma (mUC; IMvigor210) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 7s |
| Language: | English |
| ACCESSION: | WOS:000404665400006 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.104 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 104 -- Source: Wos |
